Vitamin D status and hypercholesterolemia in Spanish general population

Dermato-Endocrinology

Volumn 5, Issue 3, 2013, Pages 358-362

  Cutillas Marco, Eugenia ^a   Prosper, Amparo Fuertes ^b   Grant, William B ^c   Morales Suárez Varela, María M ^d,e,f  

^a Hospital de la Vega Lorenzo Guirao   (Spain)

^b HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^c Sunlight Nutrition and Health Research Center ^*  (United States)

^d CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^e UNIVERSITY OF VALENCIA   (Spain)

^f Center for Public Health Research CSISP   (Spain)

Author keywords

25 hydroxyvitamin D; Cholesterol; LDL cholesterol; Lipids; Statins; Vitamin D

Indexed keywords

ANTILIPEMIC AGENT; CALCIUM; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE; PHOSPHORUS; SUNSCREEN; TRIACYLGLYCEROL; VITAMIN D;

ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; POPULATION RESEARCH; SPAIN; SUN EXPOSURE; TRIACYLGLYCEROL BLOOD LEVEL; VERY ELDERLY; VITAMIN BLOOD LEVEL; VITAMIN INTAKE;

EID: 84896269894     PISSN: 19381972     EISSN: 19381980     Source Type: Journal    
DOI: 10.4161/derm.27497     Document Type: Article

References (28)

1. Hossein-nezhad A, Holick MF. Vitamin D for health: a global perspective. Mayo Clin Proc 2013; 88:720-55; http://dx.doi.org/10.1016/j.mayocp.2013.05.011; PMID:23790560
2. Cutillas-Marco E, Fuertes-Prosper A, Grant WB, Morales-Suárez- Varela M. Vitamin D deficiency in South Europe: effect of smoking and aging. Photodermatol Photoimmunol Photomed 2012; 28:159-61; http://dx.doi.org/10.1111/ j.1600-0781.2012.00649.x; PMID:22548399
3. Jorde R, Grimnes G. Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids. Prog Lipid Res 2011; 50:303-12; http://dx.doi.org/10.1016/j.plipres.2011.05.001; PMID:21640757
4. Kienreich K, Tomaschitz A, Verheyen N, Pieber T, Gaksch M, Grübler MR, Pilz S. Vitamin D and cardiovascular disease. Nutrients 2013; 5:3005-21; http://dx.doi.org/10.3390/nu5083005; PMID:23912328
5. Lips P. Worldwide status of vitamin D nutrition. J Steroid Biochem Mol Biol 2010; 121:297-300; http://dx.doi.org/10.1016/j.jsbmb.2010.02.021; PMID:20197091
6. van Holten TC, Waanders LF, de Groot PG, Vissers J, Hoefer IE, Pasterkamp G, Prins MW, Roest M. Circulating biomarkers for predicting cardiovascular disease risk; a systematic review and comprehensive overview of meta-analyses. PLoS One 2013; 8:e62080; http://dx.doi.org/10.1371/journal.pone.0062080; PMID:23630624
7. Grimnes G, Almaas B, Eggen AE, Emaus N, Figenschau Y, Hopstock LA, Hutchinson MS, Methlie P, Mihailova A, Sneve M, et al. Effect of smoking on the serum levels of 25-hydroxyvitamin D depends on the assay employed. Eur J Endocrinol 2010; 163:339-48; http://dx.doi.org/10.1530/EJE-10-0150; PMID:20479012
8. Brot C, Jorgensen NR, Sorensen OH. The influence of smoking on vitamin D status and calcium metabolism. Eur J Clin Nutr 1999; 53:920-6; PMID:10602348; http://dx.doi.org/10.1038/sj.ejcn.1600870
9. Need AG, Kemp A, Giles N, Morris HA, Horowitz M, Nordin BE. Relationships between intestinal calcium absorption, serum vitamin D metabolites and smoking in postmenopausal women. Osteoporos Int 2002; 13:83-8; PMID:11883410; http://dx.doi.org/10.1007/s198-002-8342-9
10. Bogh MK, Schmedes AV, Philipsen PA, Thieden E, Wulf HC. Vitamin D production after UVB exposure depends on baseline vitamin D and total cholesterol but not on skin pigmentation. J Invest Dermatol 2010; 130:546-53; http://dx.doi.org/10.1038/jid.2009.323; PMID:19812604
11. Ponec M, te Pas MF, Havekes L, Boonstra J, Mommaas AM, Vermeer BJ. LDL receptors in keratinocytes. J Invest Dermatol 1992; 98(Suppl):50S-6S; PMID:1588124; http://dx.doi.org/10.1111/1523-1747.ep12462204
12. Holick MF, MacLaughlin JA, Clark MB, Holick SA, Potts JT Jr., Anderson RR, Blank IH, Parrish JA, Elias P. Photosynthesis of previtamin D3 in human skin and the physiologic consequences. Science 1980; 210:203-5; PMID:6251551; http://dx.doi.org/10.1126/science.6251551
13. Gagnon C, Lu ZX, Magliano DJ, Dunstan DW, Shaw JE, Zimmet PZ, Sikaris K, Ebeling PR, Daly RM. Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab). J Clin Endocrinol Metab 2012; 97:1953-61; http://dx.doi.org/10.1210/jc.2011-3187; PMID:22442263
14. García-Bailo B, Da Costa LA, Arora P, Karmali M, El-Sohemy A, Badawi A. Plasma vitamin D and biomarkers of cardiometabolic disease risk in adult Canadians, 2007-2009. Prev Chronic Dis 2013; 10:E91; http://dx.doi.org/10. 5888/pcd10.120230; PMID:23742939
15. Pacifico L, Anania C, Osborn JF, Ferraro F, Bonci E, Olivero E, Chiesa C. Low 25(OH)D3 levels are associated with total adiposity, metabolic syndrome, and hypertension in Caucasian children and adolescents. Eur J Endocrinol 2011; 165:603-11; http://dx.doi.org/10.1530/EJE-11-0545; PMID:21753070
16. Osmancevic A, Landin-Wilhelmsen K, Larkö O, Krogstad AL. Vitamin D status in psoriasis patients during different treatments with phototherapy. J Photochem Photobiol B 2010; 101:117-23; http://dx.doi.org/10.1016/j.jphotobiol. 2010.05.008; PMID:20579901
17. Hajas A, Sandor J, Csathy L, Csipo I, Barath S, Paragh G, Seres I, Szegedi G, Shoenfeld Y, Bodolay E. Vitamin D insufficiency in a large MCTD population. Autoimmun Rev 2011; 10:317-24; http://dx.doi.org/10.1016/j.autrev. 2010.11.006; PMID:21156217
18. Elamin MB, Abu Elnour NO, Elamin KB, Fatourechi MM, Alkatib AA, Almandoz JP, Liu H, Lane MA, Mullan RJ, Hazem A, et al. Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab 2011; 96:1931-42; http://dx.doi.org/10.1210/jc.2011-0398; PMID:21677037
19. Ponda MP, Huang X, Odeh MA, Breslow JL, Kaufman HW. Vitamin D may not improve lipid levels: a serial clinical laboratory data study. Circulation 2012; 126:270-7; http://dx.doi.org/10.1161/CIRCULATIONAHA.111.077875; PMID:22718799
20. Wang H, Xia N, Yang Y, Peng DQ. Influence of vitamin D supplementation on plasma lipid profiles: a meta-analysis of randomized controlled trials. Lipids Health Dis 2012; 11:42; http://dx.doi.org/10.1186/1476-511X-11-42; PMID:22433171
21. Stancu C, Sima A. Statins: mechanism of action and effects. J Cell Mol Med 2001; 5:378-87; PMID:12067471; http://dx.doi.org/10.1111/j.1582-4934.2001. tb00172.x
22. Pérez-Castrillón JL, Vega G, Abad L, Sanz A, Chaves J, Hernandez G, Dueñas A. Effects of Atorvastatin on vitamin D levels in patients with acute ischemic heart disease. Am J Cardiol 2007; 99:903-5; http://dx.doi.org/10.1016/j.amjcard.2006.11.036; PMID:17398180
23. Sathyapalan T, Shepherd J, Arnett C, Coady AM, Kilpatrick ES, Atkin SL. Atorvastatin increases 25-hydroxy vitamin D concentrations in patients with polycystic ovary syndrome. Clin Chem 2010; 56:1696-700; http://dx.doi.org/10. 1373/clinchem.2010.144014; PMID:20817794
24. Yavuz B, Ertugrul DT, Cil H, Ata N, Akin KO, Yalcin AA, Kucukazman M, Dal K, Hokkaomeroglu MS, Yavuz BB, et al. Increased levels of 25 hydroxyvitamin D and 1,25-dihydroxyvitamin D after rosuvastatin treatment: a novel pleiotropic effect of statins? Cardiovasc Drugs Ther 2009; 23:295-9; http: //dx.doi.org/10.1007/s10557-009-6181-8; PMID:19543962
25. Liberopoulos EN, Makariou SE, Moutzouri E, Kostapanos MS, Challa A, Elisaf M. Effect of simvastatin/ezetimibe 10/10 mg versus simvastatin 40 mg on serum vitamin D levels. J Cardiovasc Pharmacol Ther 2013; 18:229-33; http://dx.doi.org/10.1177/1074248412470513; PMID:23288870
26. Makariou SE, Liberopoulos EN, Agouridis AP, Challa A, Elisaf M. Effect of rosuvastatin monotherapy and in combination with fenofibrate or omega-3 fatty acids on serum vitamin D levels. J Cardiovasc Pharmacol Ther 2012; 17:382-6; http://dx.doi.org/10.1177/1074248412439470; PMID:22431864
27. Stojadinovic O, Lebrun E, Pastar I, Kirsner R, Davis SC, Tomic-Canic M. Statins as potential therapeutic agents for healing disorders. Expert Rev Dermatol 2010; 5:689-98; http://dx.doi.org/10.1586/edm.10.60
28. Fitzpatrick TB. The validity and practicality of sunreactive skin types I through VI. Arch Dermatol 1988; 124:869-71; PMID:3377516; http://dx.doi.org/10. 1001/archderm.1988.01670060015008